TP53 and diffuse midline glioma: This suggests that drivers of tumorigenesis in diffuse midline gliomas need to combine three distinct pathways—chromatin modification alteration, PI3K pathway, and p53 mediated MAPK cross-talk (Supplementary Fig. 9).